Sundrug Co. Ltd. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
447,819
445,818
503,773
528,394
564,215
588,069
Cost of Goods Sold (COGS) incl. D&A
341,974
337,582
379,654
397,646
423,256
440,891
Gross Income
105,845
108,236
124,119
130,748
140,959
147,178
SG&A Expense
77,788
82,312
90,868
96,507
104,620
111,671
EBIT
28,057
25,924
33,025
34,056
36,081
35,234
Unusual Expense
1,381
41
193
275
41
647
Non Operating Income/Expense
386
564
313
515
433
363
Interest Expense
9
4
6
8
7
7
Pretax Income
27,178
26,569
33,277
34,424
36,598
35,071
Income Tax
11,424
10,207
11,708
11,112
11,768
11,137
Consolidated Net Income
15,754
16,362
21,569
23,312
24,829
23,933
Net Income
15,754
16,362
21,569
23,312
24,829
23,933
Net Income After Extraordinaries
15,754
16,362
21,569
23,312
24,829
23,933
Net Income Available to Common
15,754
16,362
21,569
23,312
24,829
23,933
EPS (Basic)
124.99
133.48
178.43
197.32
212.31
204.75
Basic Shares Outstanding
126
123
121
118
117
117
EPS (Diluted)
124.98
133.47
178.42
197.31
212.30
204.75
Diluted Shares Outstanding
126
123
121
118
117
117
EBITDA
33,666
32,149
39,444
41,335
43,869
43,476
Other Operating Expense
-
-
226
185
258
273
Non-Operating Interest Income
125
126
138
135
127
129
About Sundrug Co.
View Profile
